These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7492749)
1. Comparison of three human-murine heteromyeloma cell lines for formation of human hybridomas after electrofusion with human peripheral blood lymphocytes from meningococcal cases and carriers. Delvig AA; Koumaré B; Glaser RW; Wang JF; Jahn S; Achtman M Hum Antibodies Hybridomas; 1995; 6(2):42-6. PubMed ID: 7492749 [TBL] [Abstract][Full Text] [Related]
2. Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions. Glaser RW; Jahn S; Grunow R Allerg Immunol (Leipz); 1989; 35(2):123-32. PubMed ID: 2788981 [TBL] [Abstract][Full Text] [Related]
3. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line. Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878 [TBL] [Abstract][Full Text] [Related]
4. Occurrence of hybridomas producing multispecific IgM in human x (human-mouse) fusions with lymphocytes from different human immune compartments. Jahn S; Schwab J; Kiessig ST; Lukowsky A; Huhnholtz K; Mehl M; Specht U; Grunow R; von Baehr R Allerg Immunol (Leipz); 1989; 35(4):271-7. PubMed ID: 2624250 [TBL] [Abstract][Full Text] [Related]
5. Efficient electric field-induced generation of hybridomas from human B lymphocytes without prior activation in vitro. Kwekkeboom J; de Groot C; Tager JM Hum Antibodies Hybridomas; 1992 Jan; 3(1):48-53. PubMed ID: 1576322 [TBL] [Abstract][Full Text] [Related]
6. Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes. Kalantarov GF; Rudchenko SA; Lobel L; Trakht I Hum Antibodies; 2002; 11(3):85-96. PubMed ID: 12454369 [TBL] [Abstract][Full Text] [Related]
7. Lymphocyte surface marker expression on hybridomas secreting human monoclonal antibodies. Seifert M; Jahn S; Schwab J; Döcke W; Volk HD; von Baehr R Hum Antibodies Hybridomas; 1992 Apr; 3(2):86-92. PubMed ID: 1633269 [TBL] [Abstract][Full Text] [Related]
8. Strategies in the development of human monoclonal antibodies. Jahn S; Grunow R; Kiessig ST; Settmacher U; Von Baehr R Dev Biol Stand; 1990; 71():3-7. PubMed ID: 2401386 [TBL] [Abstract][Full Text] [Related]
9. Production of anti-tumor human monoclonal antibodies using different approaches. Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684 [TBL] [Abstract][Full Text] [Related]
10. Increased human hybridoma formation by electrofusion of human B cells with heteromyeloma SPAM-8 cells. Panova I; Gustafsson B Hybridoma; 1995 Jun; 14(3):265-9. PubMed ID: 7590790 [TBL] [Abstract][Full Text] [Related]
11. Development of specific IgG-producing human hybridomas by fusions of lymphocytes from actively immunized persons. Jahn S; Settmacher U; Haensel K; Kiessig S; Grunow R; Von Baehr R Hybridoma; 1989 Oct; 8(5):529-33. PubMed ID: 2680900 [TBL] [Abstract][Full Text] [Related]
12. Immortalization of magnetically separated human lymphocytes by electrofusion. Glaser RW; Volk HD; Liebenthal C; Jahn S; Grunow R Hum Antibodies Hybridomas; 1990; 1(2):111-4. PubMed ID: 1715775 [TBL] [Abstract][Full Text] [Related]
13. The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus. Grunow R; Jahn S; Porstmann T; Kiessig SS; Steinkellner H; Steindl F; Mattanovich D; Gürtler L; Deinhardt F; Katinger H J Immunol Methods; 1988 Feb; 106(2):257-65. PubMed ID: 2828478 [TBL] [Abstract][Full Text] [Related]
14. High efficiency creation of human monoclonal antibody-producing hybridomas. Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310 [TBL] [Abstract][Full Text] [Related]
15. Anti-bacterial specificities in the human fetal B cell repertoire. Settmacher U; Delvig A; Jahn S Hum Antibodies Hybridomas; 1994; 5(1-2):91-5. PubMed ID: 7858188 [TBL] [Abstract][Full Text] [Related]
16. Increase of hybridoma formation by human lymphocytes after stimulation in vitro; effect of antigen, endothelial cells, and PWM. Astaldi GC; Wright EP; Willems C; Zeijlemaker WP; Janssen MC J Immunol; 1982 Jun; 128(6):2539-42. PubMed ID: 6804563 [TBL] [Abstract][Full Text] [Related]
17. The generation of Ig-secreting UC 729-6 derived human hybridomas by electrofusion. Pratt M; Mikhalev A; Glassy MC Hybridoma; 1987 Oct; 6(5):469-77. PubMed ID: 3500113 [TBL] [Abstract][Full Text] [Related]
18. CD19+ B lymphocytes are the major source of human antibody-secreting hybridomas generated by electrofusion. Schmidt E; Leinfelder U; Gessner P; Zillikens D; Bröcker EB; Zimmermann U J Immunol Methods; 2001 Sep; 255(1-2):93-102. PubMed ID: 11470290 [TBL] [Abstract][Full Text] [Related]
19. Secretion of human monoclonal antibody after fusion of an immortal T cell line and lymphocytes from the peripheral blood of a patient with colon carcinoma. Dillman SL; Aldenderfer P; Strelkauskas A Hum Antibodies Hybridomas; 1994; 5(1-2):32-40. PubMed ID: 7858181 [TBL] [Abstract][Full Text] [Related]
20. Estimation of heterokaryon formation and hybridoma growth in murine and human cell fusions. Alkan SS; Mestel F; Jiricka J; Blaser K Hybridoma; 1987 Aug; 6(4):371-9. PubMed ID: 3623581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]